Hoba Therapeutics Raises EUR 23 Million in Series A Financing for Innovative Neuropathic Pain Treatment

Hoba Therapeutics Raises EUR 23 Million in Series A Financing for Innovative Neuropathic Pain Treatment

Danish biotech company, Hoba Therapeutics, has successfully secured EUR 23 million (USD 25 million) in a Series A financing first…